This inventor holds 2 USPTO granted patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Hye-Ran Park: Innovator in Metabolic Disorder Treatments
Introduction
Hye-Ran Park is a notable inventor based in Gyeonggi, South Korea. She has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic disorders. With a total of 2 patents, her work focuses on innovative methods to combat diseases such as obesity and diabetes.
Latest Patents
Hye-Ran Park's latest patents include a method for the treatment of metabolic disorders that utilizes benzazole derivatives as an active ingredient. This composition is designed to prevent and treat metabolic diseases by inhibiting diacylglycerol acyltransferase (DGAT), a key enzyme involved in lipid metabolism. The benzazole derivative effectively controls lipid and energy metabolism, making it a valuable tool in addressing conditions like obesity and diabetes.
Another significant patent involves indole derivatives, which also serve as an active ingredient in compositions aimed at preventing and treating metabolic disorders. Similar to her previous work, these indole derivatives inhibit DGAT, thereby aiding in the management of metabolic diseases. The ability to regulate lipid and energy metabolism positions this composition as a promising solution for combating obesity and diabetes.
Career Highlights
Hye-Ran Park is affiliated with the Korea Research Institute of Bioscience and Biotechnology. Her research and innovations have garnered attention in the scientific community, contributing to advancements in the treatment of metabolic disorders.
Collaborations
Hye-Ran Park collaborates with esteemed colleagues, including Jung Joon Lee and Young Kook Kim. Their combined expertise enhances the research efforts in developing effective treatments for metabolic diseases.
Conclusion
Hye-Ran Park's innovative work in the field of metabolic disorder treatments showcases her dedication to improving health outcomes. Her patents reflect a commitment to addressing critical health challenges, particularly obesity and diabetes. Through her research, she continues to make a significant impact in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile